Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 9/20 | 0.48 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.47 |
| ▸ | RXRA | P19793 | 7/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 7/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 7/20 | 0.42 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5924471 | 0.89 | NOTUM (0.60) | MIFNOTUMRXRAGRIN1GRIN2B | |
| SCHEMBL6923527 | 0.88 | KDM1A (0.49) | MIFNOTUMRXRAGRIN1GRIN2B | |
| SCHEMBL6926069 | 0.86 | MIF (0.45) | MIFNOTUMRXRAGRIN1GRIN2B | |
| SCHEMBL5924503 | 0.83 | MIF (0.43) | MIFNOTUMRXRAGRIN1GRIN2B | |
| SCHEMBL6505411 | 0.82 | MAOB (0.48) | MIFNOTUMRXRAGRIN1GRIN2B | |
| SCHEMBL6926066 | 0.81 | RXRA (0.41) | MIFNOTUMRXRAGRIN1GRIN2B | |
| SCHEMBL6532325 | 0.81 | NOTUM (0.47) | MIFNOTUMRXRAGRIN1GRIN2B | |
| SCHEMBL5924402 | 0.78 | KDM1A (0.45) | MIFNOTUMRXRAGRIN1GRIN2B | |
| SCHEMBL5924375 | 0.77 | NOTUM (0.56) | MIFNOTUMRXRAGRIN1GRIN2B | |
| SCHEMBL5924173 | 0.76 | MIF (0.45) | MIFNOTUMRXRAGRIN1GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004101531-A1 | ANTIINFECTIVE 1,2,3-TRIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DR. REDDY'S LABORATORIES LTD. (IN) | 2004-11-25 | — | — | WO | disclosed |